DAP Health has received the new twice-yearly injection for HIV prevention. Here's what you need to know if you're interested ...

Researchers found that lenacapavir reduced almost 100% reduction new HIV infections among participants who received it as a ...

Lenacapavir, a new HIV prevention injection, will offer six months of protection per dose at a cost of Sh6,000, according to ...

The FDA has approved a twice-yearly injection for HIV prevention following a groundbreaking clinical trial. Years before the ...

Investing.com -- 据周一发布的公告，世界卫生组织（WHO）已建议使用注射型lenacapavir预防艾滋病。 该组织还支持采用艾滋病快速检测的公共卫生方法，以支持长效注射型暴露前预防（PrEP）的推广。

美国食品药品监督管理局于2025年6月18日批准了Yeztugo，这是首个半年一次的艾滋病预防选择。吉利德科学公司已向澳大利亚、巴西、加拿大和欧洲多个国家的监管机构提交了申请。该公司目前的交易价格接近其 InvestingPro ...

HIV prevention is entering a new phase with the rise of innovative medications like the twice-yearly injectable lenacapavir.

Unfortunately, the Trump administration and the Republican majorities in Congress are putting access to lifesaving ...

KIGALI, July 14 (Xinhua) -- The 13th International AIDS Society (IAS) Conference on HIV Science officially opened Monday in the Rwandan capital of Kigali, with a strong call to accelerate access to ...

LEN is the first long-acting PrEP product that requires only two injections per year, offering an appealing alternative to ...

Lenacapavir has been incredibly promising in trials and now the World Health Organisation have officially recommended the drug for HIV prevention. Smitha Mundasad explains the difference this ...

Although Uganda participated in a groundbreaking trial for Lenacapavir—an injectable drug proven effective in preventing ...